Chinese Journal of Stroke ›› 2022, Vol. 17 ›› Issue (09): 1022-1026.DOI: 10.3969/j.issn.1673-5765.2022.09.018
Previous Articles Next Articles
Received:
2022-03-08
Online:
2022-09-20
Published:
2022-09-20
龚宇田, 黎洁洁
通讯作者:
黎洁洁 lijiejie@ttyy.org
GONG Yutian, LI Jiejie. Advances in the Relationship between IL-6 and Atherosclerotic Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 1022-1026.
龚宇田, 黎洁洁. IL-6和动脉粥样硬化性缺血性卒中的关系研究进展[J]. 中国卒中杂志, 2022, 17(09): 1022-1026.
[1] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志,2020,35(9):833-854. [2] 史怀璋,李斗,李慎茂,等. 经DSA分析1000例缺血性脑血管病华人患者的病因特点[J]. 中国脑血管病杂志,2005,2(10):437-440. [3] WOLF J,WAETZIG G H,REINHEIMER T M,et al. A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicing[J]. Biochem Biophys Res Commun,2016,470(4):870-876. [4] 张伟洁,郑宏. IL-6介导免疫炎性反应作用及其与疾病关系的研究进展[J]. 细胞与分子免疫学杂志,2017,33(5):699-703. [5] MIYAURA C,ONOZAKI K,AKIYAMA Y,et al. Recombinant human interleukin 6(B-cell stimulatory factor 2)is a potent inducer of differentiation of mouse myeloid leukemia cells(M1)[J]. Febs Letters,1988,234(1):17-21. [6] MINAMI M,INOUE M,WEI S,et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line[J]. Proc Natl Acad Sci USA,1996,93(9):3963-3966. [7] LEE P C,HO I C,LEE T C. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1,monocyte chemoattractant protein-1,and interleukin-6 in vascular smooth muscle cells[J]. Toxicol Sci,2005,85(1):541-550. [8] SCHUETT H,LUCHTEFELD M,GROTHUSEN C,et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis[J]. Thromb Haemost,2009,102(2):215-222. [9] HÄGG D,SJÖBERG S,HULTÉN L M,et al. Augmented levels of CD44 in macrophages from atherosclerotic subjects:a possible IL-6-CD44 feedback loop?[J]. Atherosclerosis,2007,190(2):291-297. [10] CHEHBOUN S,LABRECQUE-CARBONNEAU J,PASQUIN S,et al. Epstein-Barr virus-induced gene 3(EBI3)can mediate IL-6 trans-signaling[J]. J Biol Chem,2017,292(16):6644-6656. [11] HANSSON G K,HERMANSSON A. The immune system in atherosclerosis[J]. Nat Immunol,2011,12(3):204-212. [12] GREDAL H,THOMSEN B B,BOZA-SERRANO A,et al. Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke[J]. Neuroreport,2017,28(3):134-140. [13] SONG J W,SONG K S,CHOI J R,et al. Plasma level of IL-6 and its relationship to procoagulant and fibrinolytic markers in acute ischemic stroke[J]. Yonsei Med J,2006,47(2):201-206. [14] ACALOVSCHI D,WIEST T,HARTMANN M,et al. Multiple levels of regulation of the interleukin-6 system in stroke[J]. Stroke,2003,34(8):1864-1869. [15] WAJE-ANDREASSEN U,KRÅKENES J,ULVESTAD E,et al. IL-6:an early marker for outcome in acute ischemic stroke[J]. Acta Neurol Scand,2005,111(6):360-365. [16] SMITH C J,EMSLEY H C,GAVIN C M,et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume,stroke severity and long-term outcome[J/OL]. BMC Neurol,2004,4:2[2022-03-02]. https://doi.org/10. 1186/1471-2377-4-2. [17] 吴章薇,张通,赵军,等. 急性缺血性卒中后炎症因子水平与神经功能恢复的关系研究[J]. 中国卒中杂志,2021,16(10):1023-1028. [18] RIDKER P M,RIFAI N,STAMPFER M J,et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J]. Circulation,2000,101(15):1767-1772. [19] DANESH J,KAPTOGE S,MANN A G,et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease:two new prospective studies and a systematic review[J/OL]. PLoS Med,2008,5(4):e78[2022-03-02]. https://doi.org/10. 1371/journal.pmed.0050078. [20] CHEN M,YANG Y. A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke[J/OL]. J Neuroimmunol,2019,335:577004[2022-03-02]. https://doi.org/10.1016/j.jneuroim.2019.577004. [21] CAINZOS-ACHIRICA M,ENJUANES C,GREENLAND P,et al. The prognostic value of interleukin 6 in multiple chronic diseases and all-cause death:the multi-ethnic study of atherosclerosis(MESA)[J/OL]. Atherosclerosis,2018,278:217-225[2022-03-02]. https://doi.org/10.1016/j.atherosclerosis.2018.09.034. [22] JENNY N S,CALLAS P W,JUDD S E,et al. Inflammatory cytokines and ischemic stroke risk:the REGARDS cohort[J/OL]. Neurology,2019,92(20):e2375-e2384[2022-03-02]. https://doi. org/10. 1212/WNL. 0000000000007416. [23] IL6R Genetics Consortium Emerging Risk Factors Collaboration,SARWAR N,BUTTERWORTH A S,et al. Interleukin-6 receptor pathways in coronary heart disease:a collaborative meta-analysis of 82 studies[J]. Lancet,2012,379(9822):1205-1213. [24] KAPTOGE S,SESHASAI S R,GAO P,et al. Inflammatory cytokines and risk of coronary heart disease:new prospective study and updated meta-analysis[J]. Eur Heart J,2014,35(9):578-589. [25] RIDKER P M,EVERETT B M,THUREN T,et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med,2017,377(12):1119-1131. [26] RIDKER P M. Testing the inflammatory hypothesis of atherothrombosis:scientific rationale for the cardiovascular inflammation reduction trial(CIRT)[J/OL]. J Thromb Haemost,2009,7 Suppl 1:332-339[2022-03-02]. https://doi.org/10.1111/j.1538-7836.2009.03404.x. [27] NIDORF S M,EIKELBOOM J W,BUDGEON C A,et al. Low-dose colchicine for secondary prevention of cardiovascular disease[J]. J Am Coll Cardiol,2013,61(4):404-410. [28] TARDIF J C,KOUZ S,WATERS D D,et al. Efficacy and safety of low-dose colchicine after myocardial infarction[J]. N Engl J Med,2019,381(26):2497-2505. [29] KELLY P,WEIMAR C,LEMMENS R,et al. Colchicine for prevention of vascular inflammation in non-cardioembolic stroke(CONVINCE)-study protocol for a randomised controlled trial[J]. Eur Stroke J,2021,6(2):222-228. |
[1] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[2] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[3] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[4] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[5] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[6] | XU Yingxin, ZHANG Shuang, ZHOU Xiaomei, YUAN Jinglin, ZHAO Liuzhuang, YANG Haihua. Correlation of Non-Stenotic Carotid Plaque with Anterior Circulation Embolic Stroke of Undetermined Source [J]. Chinese Journal of Stroke, 2022, 17(11): 1233-1237. |
[7] | CHENG Shi, LI Jing, GUO Junping, HU Aixiang, YU Xinwei, HAN Wei, LIANG Ying, ZHANG Yuewei, JI Ruijun. Clinical Characteristics and Risk Factors of Infection in Patients with Acute Stroke during Hospitalization [J]. Chinese Journal of Stroke, 2022, 17(10): 1065-1070. |
[8] | XIANG Wei, XU Luyao, ZHANG Manman, WEI Hongchun, LIANG Zhigang. The Frequency and Influencing Factors of Asymmetrical Prominent Veins Sign on Susceptibility-Weighted Imaging in Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1097-1102. |
[9] | ZHAO Yongrui, LIU Zhanhui. Progress of Diffusion Tensor Imaging in Evaluating Motor Function Prognosis of Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1114-1119. |
[10] | ZHANG Boyu, GUO Yucheng, CUI Yuxia, LI Yingli, LYU Yumei. Seeking Medical Services Decision-Making Status and Relevant Influencing Factors in Patients with Acute Ischemic Stroke: A Review [J]. Chinese Journal of Stroke, 2022, 17(10): 1127-1132. |
[11] | WU Tingting, LIU Yafei, YAN Shixi, WU Yiping, ZHANG Zhongbo, ZAHNG Hanfei, FANG Pinping. Application of “Internet Plus” in Emergency Care of Acute Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(10): 1133-1138. |
[12] | LIU Yitong, HUANG Yanqi, LI Mingli, FENG Feng, GAO Shan, XU Weihai. Carotid Artery Geometry: A Potential Predictor for Intracranial Atherosclerosis in People at Age 60 or Less than 60 Years without Traditional Vascular Risk Factors [J]. Chinese Journal of Stroke, 2022, 17(09): 925-931. |
[13] | ZHANG Yige, ZHANG Wan, ZHANG Luyang, WANG Xin, DING Lan, WANG Yuying, PEI Lulu, FANG Hui, XU Yuming, SONG Bo. Association of Artery Occlusion and Recurrent Ischemic Stroke Related with Cerebral Artery Dissection [J]. Chinese Journal of Stroke, 2022, 17(09): 932-936. |
[14] | LYU Wei, WANG Anxin, TIAN Xue, ZHANG Xiaoli, XU Yuyuan, MENG Xia. Effect of Xinxuening Capsule on Short-term Functional Outcome in Patients with Ischemic Stroke and High Homocysteine Level [J]. Chinese Journal of Stroke, 2022, 17(09): 972-976. |
[15] | ZHANG Xinmiao, PAN Yuesong, XIANG Xianglong, WANG Yongjun, MENG Xia. Early Clinical Pathway Intervention to Improve the Key Performance Indicators of Medical Care for Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 977-984. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||